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ORIGINAL ARTICLE
INTRODUCTION
The chronic hepatitis B virus (HBV) increases
the risk of hepatocellular carcinoma (HCC) by more
than 100-fold.1 However, the molecular mechanism of
this process is not well understood. In Asia, genotypes
B and C are the predominant genotypes of HBV
infections. In a longitudinal follow-up study of
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ABSTRACT
Background: The incidence of hepatocellular carcinoma (HCC) below age 40 years old in our
institution were relatively high compared with other institutions in Asia. Hepatitis B virus (HBV) basal
core promoter (BCP) double mutations correspond with increasing age. The aim of this study was to know
if there was any role of HBV double mutations in young HCC patients.
Method: A descriptive study was performed on HBV related HCC patients in Cipto Mangunkusumo
Hospital in May 2006–November 2008. Patient were recruited consecutively and divided in to two groups,
below 40 and above 40 years old. The genotypes were examined by polymerase chain reaction (PCR)
method. The alpha feto protein (AFP) values were diagnosed based on ELISA method. The BCP A1762T/
G1764A double mutations were examined by direct sequencing.
Results: There were 49 HBV related HCC samples consist of 14 (28.5%) samples with age below 40 years
old and 35 (71.5%) samples with age above 40 years old. We only found two genotype, genotype B was
dominant in patients with HBV related HCC compare to genotype C, 43 (88%) and 6 (12%) respectively.
The increasing of AFP level above 400 ng/mL was only found in about half of the samples, 7 (50%) < 40 years
old, 19 (54%) > 40 years old. Double mutations of A1762T/G1764A in BCP occurred in 5 (36%) < 40 years old,
15 (43%) > 40 years old.
Conclusion: The incidence of HBV related HCC in young patients were relatively high. The proportion of
patients with AFP level < 400 ng/mL in patients below 40 years old were higher compared to patients above
40 years.
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426 chronic hepatitis B patients for up to 5 years in
Hong Kong, genotype C HBV was found to be asso-
ciated with higher risk of HCC than genotype B HBV.2
However, the unpublished study held in Division of
Hepatology, Faculty of Medicine University of
Indonesia showed that incident of genotype B was
predominant than genotype C. The HBV genomic
mutations occur due to a spontaneous error rate of
viral reverse transcriptase and evolving of HBV
genome under the antiviral pressure of host immune
response. Specific mutations may affect
the translation of hepatitis B e antigen (HBeAg), as
well as the replication of HBV and thus may modify
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the clinical outcome of HBV infection and contribute
to HCC development.3 Recently, several studies have
shown that A1762T and G1764A mutations were
associated with the aggressive progression of liver
disease, in which inactive carriers have developed
active hepatitis, and eventually liver cirrhosis and HCC.4
Mutations in the basal core promoter (BCP) at
nucleotide 1762 (A1762T) and nucleotide 1764
(G1764A) have been described elsewhere.5 These
mutations resulted in coding changes at codons 130
and 131 in the open reading frame x (ORF x) protein
changing lysine to methionin and valine to isoleucine,
respectively. The incidence of HCC below age 40 years
old in our institution were relatively high compared
with other institutions in Asia. The HBV BCP double
mutations correspond with increasing age. The aim of
this study was to know if there iwas any role of HBV
double mutations in young HCC patients.
METHOD
A descriptive study was performed on the HBV
related HCC patients in Cipto Mangunkusumo
hospital in May 2006 – November 2008. Patient were
recruited consecutively and divided in to two groups,
below 40 and above 40 years old.
HBV genotyping; the existence of genotypes was
examined by polymerase chain reaction (PCR) method.
While the alpha feto protein (AFP) values were based
on ELISA method. The BCP A1762T/G1764A double
mutations were examined by direct sequencing.
RESULTS
Age-related Distribution of HBV Genotype in
Patients with HCC
In order to investigate the age-related distribution
of HBV genotypes in HCC patients, they were
classified into two age groups (< 40 and > 40 years).
There were 49 HBV related HCC samples consist of
14 (28.5%) samples with age below 40 years old and
35 (71.5%) samples with age above 40 years old.
The gender of the samples was dominated by male
36 (73.5%) overall, and if we breakdown according to
age group consist of 12 (86%) < 40 years old, 24 (71%)
> 40 years old, respectively. We only found two
genotype, genotype B was dominant in patients with
HBV related HCC compare to genotype C, 43 (88%)
and 6 (12%) respectively, consist of 12 (86%)
< 40 years old, 31 (91%) > 40 years old, respectively.
The increasing of AFP level above 400 ng/mL was
only found in about half of the samples, 7 (50%) <
40 years old 19 (54%) > 40 years old. Double
mutations of A1762T/G1764A in BCP occurred in
5 (36%) < 40 years old, 15 (43%) > 40 years old.
Table 1. Baseline characteristics of the study (n = 49) 
Variable n (%) 
Sex  
 Male 36 (73%) 
 Female 13 (27%) 
Age (year)  
 < 40 14 (29%) 
 > 40 35 (71%) 
Genotype  
 B 43 (88%) 
 C 6 (12%) 
AFP level (ng/mL)  
 < 400 23 (43%) 
 > 400 26 (53%) 
Double mutation  
 Yes 20 (41%) 
 No 29 (59%) 
 
 
Figure 1. HBV related hepatocellular carcinoma
Figure 2. HBV related hepatocellular, genotype
Figure 3. HBV related hepatocellular carcinoma, AFP level
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  Figure 4. HBV related hepatocellular carcinoma double mutation
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DISCUSSION
It has been reported that genotype C HBV is more
aggressive for the development of liver cirrhosis and
HCC.6 Interestingly, in our study the mutation rate of
A1762T/G1764A of genotype B is dominant compare
to genotype C. Based on the analysis, mutation rate of
A1762T/G1764A in genotype B is much higher than
genotype C. This result is different from another
country in Asia. The high frequency of A1762T/
G1764A mutations in genotype B correlates with an
increased risk of HCC. Recent studies have shown
that genotype B with A1762T/G1764A mutations is also
associated with an increased risk of HCC
development.7 These results provide further support
for the important role played by A1762T/G1764A
mutations in the progression of HBV-associated
diseases, including HCC.
The contribution of HBV to the pathogenesis of
liver cancer is multi factorial and complicated by
the identification of mutant variants of HBV that
modulate the carcinogenesis process.8 Clinical
studies have shown that HBV patients with A1762T/
G1764A mutations have low levels of HBeAg and are
often associated with HCC.
The role of HBV genotype and mutants in disease
progression continue to be of great interest. Several
mechanisms of hepatocarcinogenesis related to
the BCP A1762T/G1764A mutant have been
hypothesized. It has been proposed that the BCP
mutation may enhance HBV virulence by increasing
host immune response, increasing viral replication or
altering the coding region for the X antigen. The BCP
mutations appears to enhance the efficiency of viral
replication either by modulating the relative level of
the precore and core RNA’s or by creating
a hepatocyte nuclear factor 1 transcription factor
binding site. The incidence of HBV double mutations
increased corresponds with the age. It is needed to be
proven that BCP plays an important role in young age
HBV related HCC. The other interesting finding was
the AFP level in patients below age 40 was relatively
high (50%) compared with patients above age
40 (46%), and also didn’t consistent with previous
reports.
CONCLUSION
The incidence of HBV related HCC in young
patients (< 40 years old) were relatively high (up to
29%). The proportion of patients with AFP level < 400
ng/mL in patients below 40 years old were higher
compared to patients above 40. These findings should
emphasize more detail study needed to reveal
the pathogenesis of HCC in our region.
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Figure 5. HBV related hepatocellular carcinoma double mutation
and genotype
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